Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(25.0%)
N/A
1(25.0%)
Phase 2
1(25.0%)
Phase 4
1(25.0%)
4Total
Phase 1(1)
N/A(1)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04606836Phase 4Unknown

ICNBs for Post-op Pain in Breast Surgery

Role: collaborator

NCT00711373Phase 2Unknown

Vascularized Composite Allotransplantation of the Hand

Role: collaborator

NCT01530919Completed

Minimally Invasive Radioguided Parathyroidectomy

Role: collaborator

NCT00474461Phase 1Completed

Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)

Role: collaborator

NCT00006087Not ApplicableUnknown

Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer

Role: lead

All 5 trials loaded